Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net loss	$ (99,095)	$ (5,261)
Net income from discontinued operations (including gain on sale of MTI Instruments of $7,751 for the year ended December 31, 2022)	(7,921)	(1,127)
Net loss from continuing operations	(107,016)	(6,388)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation expense	18,731	2,124
Amortization expense	9,483	1,579
Stock-based compensation	3,673	1,941
Consultant stock compensation	179	104
Deferred income taxes	(1,388)	41
Impairment on fixed assets	47,372
Amortization of operating lease asset	202	169
Impairment on equity investment	750
Loss on debt extinguishment and revaluation, net	11,130
Amortization on deferred financing costs and discount on notes	6,538	1,876
Loss on sale of fixed assets	4,089
Changes in operating assets and liabilities:
Accounts receivable	211	(471)
Prepaid expenses and other current assets	146	(956)
Other long-term assets	(29)	(812)
Accounts payable	553	2,765
Deferred revenue	137	316
Operating lease liabilities	(197)	(156)
Other liabilities	(308)	306
Accrued liabilities	(374)	2,197
Net cash (used in) provided by operating activities	(6,118)	4,635
Net cash provided by operating activities- discontinued operations	369	917
Investing Activities
Purchases of property, plant, and equipment	(63,684)	(45,792)
Purchases of intangible assets	(76)	(1,567)
Proceeds from disposal on property, plant, and equipment	2,605
Deposits of equipment, net	6,441	(9,909)
Net cash used in investing activities	(54,714)	(57,268)
Net cash provided by (used in) investing activities- discontinued operations	9,084	(37)
Financing Activities
Proceeds from preferred offerings	16,658	27,965
Proceeds from common stock offering	2,858	17,250
Proceeds from notes and debt issuance	30,543	15,000
Costs of preferred offering	(1,910)	(2,707)
Costs of common stock offering	(504)	(1,847)
Costs of notes and short-term debt issuance	(2,078)	(1,338)
Cash dividend distribution on preferred stock	(3,852)	(630)
Borrowings under line of credit		1,000
Payments on NYDIG loans and line of credit	(4,491)
Contributions from non-controlling interest	4,786
Proceeds from stock option exercises	153	102
Proceeds from common stock warrant exercises	779	4,586
Net cash provided by financing activities	42,942	59,381
(Decrease) increase in cash & restricted cash-continuing operations	(17,890)	6,748
Increase in cash & restricted cash- discontinued operations	9,453	880
Cash & restricted cash – beginning of period	10,258	2,630
Cash & restricted cash – end of period	1,821	10,258
Supplemental Disclosure of Cash Flow Information
Noncash equipment financing	4,620
Interest paid on NYDIG loans and line of credit	1,311	6
Proceed receivable from sale of MTI Instruments	295
Notes converted to common stock	3,295
Warrant consideration in relation to promissory notes and convertible notes	14,602
Promissory note conversion to preferred shares	15,236
Noncash proceed on sale of equipment	210
Purchase of miner equipment using restricted stock		(207)
Registration fees in prepaids and accounts payable		(200)
Termination shares issued in conjunction with merger for intangible assets		1,917
Warrants exercised prior to year-end not received until subsequent period		206
Share consideration in relation to strategic pipeline contract		33,000
Deferred tax liability in relation to strategic pipeline contract		$ 10,934